History
  • No items yet
midpage
Teva Pharm. United States, Inc. v. Sandoz, Inc.
135 S. Ct. 831
| SCOTUS | 2015
Read the full case

Background

  • Teva owns a patent claiming copolymer-1 (active ingredient of Copaxone) with a "molecular weight of about 5 to 9 kilodaltons." Teva sued Sandoz for infringement after Sandoz sought to market a generic.
  • Sandoz argued the claim was indefinite under 35 U.S.C. § 112 because "molecular weight" could be measured in multiple scientifically distinct ways (peak/most prevalent, number-average, or weight-average), and the claim did not specify which method.
  • The district court heard expert testimony, found a skilled artisan would understand the patent to refer to peak (most prevalent) molecular weight, and held the claim definite and valid.
  • The Federal Circuit reviewed the district court’s claim construction (including subsidiary factual findings) de novo, reversed, and held the claim indefinite.
  • The Supreme Court granted certiorari to decide the appropriate standard of appellate review for district-court subsidiary factual findings made during patent claim construction.

Issues

Issue Plaintiff's Argument (Teva) Defendant's Argument (Sandoz) Held
What standard should an appellate court apply when reviewing district-court subsidiary factual findings made during claim construction? Deferential review: district-court factual findings (e.g., expert credibility about technical meaning) should be accepted unless clearly erroneous. De novo review of the entire claim construction is appropriate because claim construction is principally a legal exercise about documents; applying two standards is difficult and risks inconsistency. The Court held that appellate courts must review subsidiary factual findings for clear error under Fed. R. Civ. P. 52(a)(6), while reviewing the ultimate legal claim construction de novo.
Whether Markman created an exception to Rule 52(a)(6) such that all aspects of claim construction are reviewed de novo. Markman did not create any exception to Rule 52(a)(6); it recognized "evidentiary underpinnings" that may require factual findings. The Federal Circuit interpreted Markman to permit de novo review of subsidiary findings. Markman treated ultimate claim construction as a legal question but acknowledged subsidiary factual issues; Rule 52(a)(6) still governs those subsidiary factual findings.
Did the Federal Circuit err in this case by failing to apply clear-error review to the district court’s factual finding about how a skilled artisan would read Figure 1? The district court credited Teva’s expert explaining an expected chromatogram peak shift; that factual finding should have been accepted unless clearly erroneous. The Federal Circuit discounted the district-court factual finding and reviewed de novo. The Supreme Court held the Federal Circuit erred by not applying clear-error review to that subsidiary factual determination; vacated and remanded.
How should courts treat intrinsic vs extrinsic evidence in claim construction on appeal? Intrinsic-only constructions are legal and reviewed de novo; when extrinsic evidence raises disputed subsidiary facts, those factual findings are reviewed for clear error. (Overlaps) Argued uniformity favors de novo review even when extrinsic evidence is used. Court reiterated: intrinsic evidence → legal question (de novo); extrinsic fact disputes → factual findings (clear error), then ultimate legal construction reviewed de novo.

Key Cases Cited

  • Markman v. Westview Instrs., 517 U.S. 370 (1996) (claim construction is for the court; acknowledged evidentiary underpinnings)
  • Anderson v. Bessemer City, 470 U.S. 564 (1985) (appellate courts must not overturn district-court factual findings unless clearly erroneous)
  • Pullman-Standard v. Swint, 456 U.S. 273 (1982) (Rule 52(a) has no categorical exceptions for types of factual findings)
  • Cybor Corp. v. FAS Techs., 138 F.3d 1448 (Fed. Cir. 1998) (Federal Circuit precedent treating claim construction review as entirely de novo)
  • Dennison Mfg. Co. v. Panduit Corp., 475 U.S. 809 (1986) (subsidiary factual determinations in patent cases are subject to clear-error review)
  • Graver Tank & Mfg. Co. v. Linde Air Prods. Co., 339 U.S. 605 (1950) (patent adjudication often depends on technical familiarity; trial courts are well positioned)
  • Great Northern R. Co. v. Merchants Elevator Co., 259 U.S. 285 (1922) (construction of written instruments may involve subsidiary factual issues)
  • Ornelas v. United States, 517 U.S. 690 (1996) (appellate review framework: legal conclusions de novo, factual findings for clear error)
Read the full case

Case Details

Case Name: Teva Pharm. United States, Inc. v. Sandoz, Inc.
Court Name: Supreme Court of the United States
Date Published: Jan 20, 2015
Citation: 135 S. Ct. 831
Docket Number: No. 13–854.
Court Abbreviation: SCOTUS